• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吸入后尿中色甘酸钠定量分析的离子对液相色谱法的建立与验证

Development and validation of an ion-pair liquid chromatographic method for the quantitation of sodium cromoglycate in urine following inhalation.

作者信息

Aswania O A, Corlett S A, Chrystyn H

机构信息

Postgraduate Studies in Pharmaceutical Technology, School of Pharmacy, University of Bradford, UK.

出版信息

J Chromatogr B Biomed Sci Appl. 1997 Mar 7;690(1-2):373-8. doi: 10.1016/s0378-4347(96)00382-9.

DOI:10.1016/s0378-4347(96)00382-9
PMID:9106069
Abstract

An ion-pair liquid high-performance chromatography method with solid-phase extraction for measuring urinary concentrations of sodium cromoglycate following inhalation has been developed and validated. Sodium cromoglycate was extracted from urine on a 100-mg phenyl cartridge (Isolute, Jones Chromatography) and then quantified on a 25-cm C8 Spherisorb 5 microns stationary phase with a mobile phase of methanol-0.045 M phosphate buffer-0.05 M dodecyl triethyl ammonium phosphate (550:447.6:2.4, v/v) pH 2.3, at 0.85 ml min-1 using nedocromil sodium as an internal standard and UV detection at 238 nm. The inter- and intra-day reproducibilities were 8.33 and 13.63%, respectively, at 0.25 mg l-1. The limit of determination for sodium cromoglycate was 0.25 mg l-1 (with a signal-to-noise ratio of greater than 10:1). Following oral and inhaled administration of 20 mg of sodium cromoglycate to eight healthy volunteers, the mean and S.D. of sodium cromoglycate excreted in the urine at 0.5, 1 and 24 h post-dose were 0.02, 0.05 and 0.33%, and 0.16, 0.30 and 1.55% of the dose, respectively. The urinary recovery of sodium cromoglycate at 0.5 and 1 h following inhalation can therefore be used to compare the amount of drug reaching the respiratory tract using different sodium cromoglycate inhaled products or inhalation methods.

摘要

已开发并验证了一种采用固相萃取的离子对液相高效色谱法,用于测定吸入后尿中色甘酸钠的浓度。色甘酸钠在100毫克苯基柱(Isolute,Jones色谱)上从尿液中萃取,然后在25厘米的C8 Spherisorb 5微米固定相上进行定量,流动相为甲醇-0.045 M磷酸盐缓冲液-0.05 M十二烷基三乙铵磷酸盐(550:447.6:2.4,v/v),pH 2.3,流速为0.85毫升/分钟,以内色奈甲酸钠为内标,在238纳米处进行紫外检测。在0.25毫克/升时,日间和日内重现性分别为8.33%和13.63%。色甘酸钠的测定限为0.25毫克/升(信噪比大于10:1)。对8名健康志愿者口服和吸入20毫克色甘酸钠后,给药后0.5、1和24小时尿中排出的色甘酸钠的平均值和标准差分别为剂量的0.02%、0.05%和0.33%,以及0.16%、0.30%和1.55%。因此,吸入后0.5和1小时色甘酸钠的尿回收率可用于比较使用不同色甘酸钠吸入产品或吸入方法到达呼吸道的药物量。

相似文献

1
Development and validation of an ion-pair liquid chromatographic method for the quantitation of sodium cromoglycate in urine following inhalation.吸入后尿中色甘酸钠定量分析的离子对液相色谱法的建立与验证
J Chromatogr B Biomed Sci Appl. 1997 Mar 7;690(1-2):373-8. doi: 10.1016/s0378-4347(96)00382-9.
2
Validation of a high-performance liquid chromatography assay for urinary nedocromil sodium following oral and inhaled administration.口服和吸入给药后尿奈多罗米钠的高效液相色谱测定法的验证
J Chromatogr B Biomed Sci Appl. 1998 Nov 6;718(2):290-5. doi: 10.1016/s0378-4347(98)00379-x.
3
Determination of disodium cromoglycate in human urine by high-performance liquid chromatography with post-column photoirradiation-fluorescence detection.
Analyst. 1997 Jul;122(7):715-7. doi: 10.1039/a608152e.
4
Relative bioavailability of sodium cromoglycate to the lung following inhalation, using urinary excretion.通过尿液排泄测定吸入后色甘酸钠对肺部的相对生物利用度。
Br J Clin Pharmacol. 1999 Jun;47(6):613-8. doi: 10.1046/j.1365-2125.1999.00937.x.
5
Relative lung and systemic bioavailability of sodium cromoglycate inhaled products using urinary drug excretion post inhalation.
Biopharm Drug Dispos. 2002 May;23(4):159-63. doi: 10.1002/bdd.308.
6
Relative lung bioavailability of generic sodium cromoglycate inhalers used with and without a spacer device.使用和不使用储雾罐装置的非专利色甘酸钠吸入器的相对肺部生物利用度。
Pulm Pharmacol Ther. 2001;14(2):129-33. doi: 10.1006/pupt.2001.0279.
7
A simple pharmacokinetic method to evaluate the pulmonary dose in clinical practice--analyses of inhaled sodium cromoglycate.一种在临床实践中评估肺部剂量的简单药代动力学方法——吸入性色甘酸钠分析
Respir Med. 2004 Jan;98(1):9-16. doi: 10.1016/j.rmed.2003.08.010.
8
Determination of the relative bioavailability of nedocromil sodium to the lung following inhalation using urinary excretion.采用尿排泄法测定吸入用奈多罗米钠在肺部的相对生物利用度。
Eur J Clin Pharmacol. 1998 Aug;54(6):475-8. doi: 10.1007/s002280050496.
9
Determination of sodium cromoglycate in human plasma by liquid chromatography with tandem mass.液相色谱-串联质谱法测定人血浆中色甘酸钠的含量
Biomed Chromatogr. 2008 Sep;22(9):1021-7. doi: 10.1002/bmc.1022.
10
Comparison of three treatment regimens of inhaled sodium cromoglycate in the management of adult patients with severe, steroid-dependent asthma.吸入色甘酸钠三种治疗方案用于重度、依赖类固醇的成年哮喘患者管理的比较
Ann Allergy Asthma Immunol. 1998 Jun;80(6):494-8. doi: 10.1016/S1081-1206(10)63073-6.

引用本文的文献

1
Development and Validation of a Liquid Chromatography-Mass Spectrometry Assay for Determination of Cromolyn Sodium in Skin Permeation Studies.用于皮肤渗透研究中测定色甘酸钠的液相色谱-质谱分析法的开发与验证
J Anal Methods Chem. 2022 Apr 21;2022:7437905. doi: 10.1155/2022/7437905. eCollection 2022.
2
Development of Advanced Chemometric-Assisted Spectrophotometric Methods for the Determination of Cromolyn Sodium and Its Alkaline Degradation Products.开发高级化学计量学辅助分光光度法测定克仑特罗钠及其碱性降解产物。
Molecules. 2020 Dec 16;25(24):5953. doi: 10.3390/molecules25245953.
3
Methods to identify drug deposition in the lungs following inhalation.
识别吸入后药物在肺部沉积的方法。
Br J Clin Pharmacol. 2001 Apr;51(4):289-99. doi: 10.1046/j.1365-2125.2001.01304.x.
4
Relative bioavailability of sodium cromoglycate to the lung following inhalation, using urinary excretion.通过尿液排泄测定吸入后色甘酸钠对肺部的相对生物利用度。
Br J Clin Pharmacol. 1999 Jun;47(6):613-8. doi: 10.1046/j.1365-2125.1999.00937.x.